Nuvectis Pharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q2 2024 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q3 2024 | 2 | -$0.28 | -$0.23 | -$0.25 |
| Q1 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q3 2025 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q4 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
Nuvectis Pharma, Inc. Earnings Date And Information
Nuvectis Pharma, Inc. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $-0.24 earnings per share for the quarter, topping analysts' consensus estimates of $-0.26 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Nuvectis Pharma, Inc. has generated $-1 earnings per share over the last year ($-1.43 diluted earnings per share) and currently has a price-to-earnings ratio of -4.36. Nuvectis Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Nuvectis Pharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2024 | Q3 2024 | -$0.26 | -$0.24 | 0.02 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.26 | -$0.26 | 0 | $0 | $0 |
| 05/07/2024 | Q1 2024 | -$0.40 | -$0.25 | 0.15 | $0 | |
| 03/05/2024 | Q4 2023 | -$0.40 | -$0.38 | 0.02 | $-4,101,000 | |
| 11/08/2023 | Q3 2023 | -$0.38 | -$0.37 | 0.01 | $0 | |
| 08/09/2023 | Q2 2023 | -$0.34 | -$0.38 | -0.04 | $0 | |
| 05/10/2023 | Q1 2023 | -$0.44 | -$0.27 | 0.17 | $4.10 M | |
| 03/27/2023 | Q4 2022 | -$0.45 | $149,000 | |||
| 11/08/2022 | Q3 2022 | -$0.27 | -$0.42 | -0.15 | $0 | |
| 08/10/2022 | Q2 2022 | -$0.28 | $0 | |||
| 05/12/2022 | Q1 2022 | -$0.32 | $0 | |||
| 03/23/2022 | Q4 2021 | -$0.18 | $4,000 | |||
| 09/30/2021 | Q3 2021 | -$0.39 | $0 | |||
| 06/30/2021 | Q2 2021 | -$0.47 | $0 | |||
| 03/31/2021 | Q1 2021 | -$0.00 | $0 |
Nuvectis Pharma, Inc. Earnings: Frequently Asked Questions
-
When is Nuvectis Pharma, Inc.'s earnings date?
Nuvectis Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
-
Did Nuvectis Pharma, Inc. beat their earnings estimates last quarter?
In the previous quarter, Nuvectis Pharma, Inc. (:NVCT) reported $-0.24 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.26 by $0.02.
-
How can I listen to Nuvectis Pharma, Inc.'s earnings conference call?
The conference call for Nuvectis Pharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Nuvectis Pharma, Inc.'s conference call transcript?
The conference call transcript for Nuvectis Pharma, Inc.'s latest earnings report can be read online.
-
How much profit does Nuvectis Pharma, Inc. generate each year?
Nuvectis Pharma, Inc. (:NVCT) has a recorded net income of $0. Nuvectis Pharma, Inc. has generated $-1.43 earnings per share over the last four quarters.
-
What is Nuvectis Pharma, Inc.'s price-to-earnings ratio?
Nuvectis Pharma, Inc. (:NVCT) has a price-to-earnings ratio of -4.36 and price/earnings-to-growth ratio is -0.42.
